Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
Hlavní autoři: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
1998
|
Podobné jednotky
-
Monoclonal-antibody therapy in systemic vasculitis.
Autor: Mathieson, P, a další
Vydáno: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
Autor: Mathieson, P, a další
Vydáno: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
Autor: Lockwood, C, a další
Vydáno: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Autor: Lockwood, C, a další
Vydáno: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
Autor: Isaacs, J, a další
Vydáno: (1993)